通过收购基因泰克，罗氏已经在其贫血症研究方面，增加了抗癌药和其他潜在有利可图的、有前景的治疗方法。
By taking over Genentech, Roche has added promising drugs for cancer and other potentially lucrative treatments to its otherwise anaemic research pipeline.
多年以来，尽管该药同心脏病有关的警钟在其他国家和法国医学界已经敲响，直到2009年它才退出法国市场。
Despite the ringing of alarm bells over the years about its links to heart disease, both in other countries and within the French medical profession, the drug was not withdrawn in France until 2009.
应用推荐